Example: dental hygienist

Search results with tag "Monographs"

IARC Monographs on the Evaluation of Carcinogenic Risks to ...

IARC Monographs on the Evaluation of Carcinogenic Risks to ...

monographs.iarc.who.int

Section of IARC Monographs, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France, in order that the agent may be considered for re-evaluation by a future Working Group. Although every effort is made to prepare the monographs as accurately as possible, mistakes may occur.

  Monographs

IARC MONOGRAPHS ON THE EVALUATION OF …

IARC MONOGRAPHS ON THE EVALUATION OF

monographs.iarc.who.int

to include consideration of exposures to complex mixtures of chemicals (which occur, for example, in some occupations and as a result of human habits) and of exposures to other agents, such as radiation and viruses. With Supplement 6 (IARC, 1987a), the title of the series was modified from IARC Monographs on the Evaluation of the Carcino-

  Evaluation, Iarc, Monographs, Exposure, Iarc monographs on the evaluation of

General Notices, Monographs, General Chapters, Reagents ...

General Notices, Monographs, General Chapters, Reagents ...

www.uspnf.com

General Notices, Monographs, General Chapters, Reagents, and Tables Affected by Changes Appearing in NF 35 Page citations refer to the pages of NF 35. Note—In the list below, if a section is new or if a subsection is added to or deleted from an existing section, it is labeled as such in parentheses after the section or subsection name.

  Monographs

USP 39 Official Monographs / Calcium 1

USP 39 Official Monographs / Calcium 1

www.uspnf.com

USP 39 Official Monographs / Calcium 1. Acceptance criteria: NMT 10 ppm Calcium Citrate • LIMIT OF FLUORIDE [NOTE—Prepare and store all solutions in plastic containers.] Standard stock solution: 1000µg/mL of fluoride ion from USP Sodium Fluoride RS in water Standard solution: 5µg/mL of fluoride ion from Stan-dard stock solution.

  Monographs, Officials, Official monographs

ALOE VERA - IARC Monographs on the Identification of ...

ALOE VERA - IARC Monographs on the Identification of ...

monographs.iarc.who.int

IARC MONOGRAPHS – 108 40 been traditionally used as the laxative (Eur Ph, 2008). (a) Aloe vera gel extract The inner leaf pulp of the Aloe vera plant contains large, thin-walled cells that produce gel, the clear, mucilaginous, and aqueous extract of the inner central area of the leaf pulp (Fig. 1.2). Aloe vera gel serves as the water and energy

  Iarc, Monographs, Vera, Aloe, Iarc monographs, Aloe vera

IARC Monographs evaluate consumption of red meat and ...

IARC Monographs evaluate consumption of red meat and ...

www.iarc.who.int

PRESS RELEASE N° 240 26 October 2015. IARC Monographs evaluate consumption of red meat and processed meat . Lyon, France, 26 October 2015 – The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization, has the carcinogenicity of evaluated the consumption of red

  International, Research, Iarc, Monographs, Agency, International agency for research, Iarc monographs

EXPOSURE TO ARSENIC: A MAJOR PUBLIC HEALTH CONCERN

EXPOSURE TO ARSENIC: A MAJOR PUBLIC HEALTH CONCERN

www.who.int

Lyon, International Agency for Research on Cancer (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100) [summary in Straif K et al. (2009). A review of human carcinogens—Part C: Metals, arsenic, dusts, and fibres.

  International, Research, Iarc, Monographs, Agency, International agency for research, Iarc monographs

Material Safety Data Sheet U.S. Department of Labor

Material Safety Data Sheet U.S. Department of Labor

www.ilpi.com

IARC Monographs? OSHA Regulated? Signs and Symptoms of Exposure Medical Conditions Generally Aggravated by Exposure Emergency and First Aid Procedures Section VII—Precautions for Safe Handling and Use Steps to Be Taken in Case Material Is Released or Spilled Waste Disposal Method

  Iarc, Monographs, Iarc monographs

SAFETY DATA SHEET

SAFETY DATA SHEET

content.oppictures.com

IARC Monographs. Overall Evaluation of Carcinogenicity Not listed. OSHA Specifically Regulated Substances (29 CFR 1910.1001-1053) Not regulated. US. National Toxicology Program (NTP) Report on Carcinogens Not listed. Reproductive toxicity This product is not expected to cause reproductive or developmental effects. Specific target organ toxicity -

  Sheet, Data, Safety, Iarc, Monographs, Safety data sheet, Iarc monographs

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

media.distributordatasolutions.com

May 02, 2018 · IARC Monographs on the Evaluation of Carcinogenic Risks to Humans No carcinogenic components identified US. National Toxicology Program (NTP) Report on Carcinogens: No carcinogenic components identified Product Name: RIDGID Dark Thread Cutting Oil (United States)

  Iarc, Monographs, Iarc monographs

Impactos ambientales del petróleo - Greenpeace

Impactos ambientales del petróleo - Greenpeace

www.greenpeace.org

5.- IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: occupational exposures to petroleum refining; crude oil and major petroleum fuels. Volume 45. IARC, Lyon 1989. 6.- Campbell D, Cox D, Crum J, Foster K, Christie P. Initial effects of the grounding of the tanker Braer on health in Shetland.

  Iarc, Monographs, Iarc monographs, Greenpeace

Hazard Communication Standard: Safety Data Sheets

Hazard Communication Standard: Safety Data Sheets

www.osha.gov

International Agency for Research on Cancer (IARC) Monographs (latest editions) or found . to be a potential carcinogen by OSHA. 5. Section 12: Ecological Information (non-mandatory) This section provides information to evaluate the environmental impact of the chemical(s) if it .

  International, Research, Sheet, Data, Safety, Iarc, Monographs, Agency, Safety data sheet, International agency for research

SAFETY DATA SHEET - Sprayway, Inc

SAFETY DATA SHEET - Sprayway, Inc

www.spraywayinc.com

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: No carcinogenic components identified US. National Toxicology Program (NTP) Report on Carcinogens: No carcinogenic components identified US. OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050): No carcinogenic components identified Germ Cell Mutagenicity In vitro

  Sheet, Data, Safety, Iarc, Monographs, Safety data sheet, Iarc monographs

Official Monographs - Pmda

Official Monographs - Pmda

www.pmda.go.jp

chloric acid TS (1 in 100,000) as directed under Ultraviolet-visible Spectrophotometry <2.24>, and compare the spectrum with the Reference Spectrum: both spectra exhibit similar in-tensities of absorption at the same wavelengths. (2) Determine the infrared absorption spectrum of Acebutolol Hydrochloride, previously dried, as directed in

  Monographs, Ultraviolet, Visible, Spectrophotometry, Visible spectrophotometry

POLYVINYL ALCOHOL (PVA)

POLYVINYL ALCOHOL (PVA)

www.fao.org

IARC Working group, feb. 7-13,1978,Lyon, France. World Health Organization (WHO). International Agerny for Research on Cancer (IARC); Lyon, France. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 19, pp. 341-366. Title: Microsoft Word - 2004-02-24 CTA 61 PVA.doc Author: ML_Admin

  Iarc, Monographs, Alcohols, Polyvinyl alcohol, Polyvinyl, Iarc monographs

シンレキ工業株式会社|エムコール|ロードプラスターK| …

シンレキ工業株式会社|エムコール|ロードプラスターK| …

www.shinreki.co.jp

IARC ( 1985) Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol.35 SUPPLEMENT 7 No.176 (2009.7) 044—366— 1617 044—366—1618 kenkyu@shinreki.co.jp El 7/7 8 17: 30 . Created Date:

  Iarc, Monographs

List of classifications by cancer sites with sufficient or ...

List of classifications by cancer sites with sufficient or ...

monographs.iarc.who.int

IARC Monographs Volumes 1–130a. Cancer site . Carcinogenic agents with . sufficient evidence. in humans . Agents with . limited evidence. in humans . Lip, oral cavity, and pharynx; Lip . Hydrochlorothiazide . Solar radiation : Oral cavity . Acetaldehyde associated with …

  With, Site, Iarc, Monographs, Classification, Cancer, Iarc monographs, Classifications by cancer sites with

OFFICIAL, EFFECTIVE DATE 11/04/2021

OFFICIAL, EFFECTIVE DATE 11/04/2021

www.usp.org

scope at this time are pending monographs for excipients, and novel excipients. At such time as official procedures are developed for those items, they will be included in this guideline. Please contact USP Customer Engagement for Excipients. for additional information concerning questions for items that are out of scope. 3.

  Monographs, Officials

The United States Pharmacopeia - World Health …

The United States Pharmacopeia - World Health

www.who.int

alternatives to official compendial procedures. Pharm Forum. 2009;35 (3):772-778. Koch WF, Hauck WW, de Mars SS, Williams RL. Measurement science for food and drug monographs: toward a global system. Pharm Res. 2010;27:1203-1207. USP Council of Experts, USP Reference Standards Committee,

  Health, United, States, World, Monographs, World health, Pharmacopeia, Officials, The united states pharmacopeia

MONOGRAPHS (USP) - USP–NF | USP-NF

MONOGRAPHS (USP) - USP–NF | USP-NF

www.uspnf.com

Standard stock solution—Combine 3.0 mL of ferric chlo-ride CS, 3.0 mL of cobaltous chloride CS, 2.4 mL of cupric sulfate CS, and 1.6 mL of dilute hydrochloric acid (10 g per L). Standard solution—[NOTE—Prepare the Standard solu-tion immediately before use.] Transfer 1.0 mL of Standard stock solution to a 100-mL volumetric flask, dilute ...

  Monographs, Chlo

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

ca.gsk.com

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SHINGRIX Herpes Zoster vaccine (non-live recombinant, AS01B adjuvanted) Suspension for injection, 50 mcg Varicella Zoster Virus (VZV) glycoprotein E (gE), Intramuscular Injection Active Immunizing Agent GlaxoSmithKline Inc. 7333Mississauga Road Mississauga, Ontario L5N 6L4

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Shingrix, Product monograph including patient medication information shingrix

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

pdf.hres.ca

AFLURIA® TETRA (Inactivated Influenza Vaccine (Split Virion)) Product Monograph Page 1 of 24 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION AFLURIA® TETRA Quadrivalent Inactivated Influenza Vaccine (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07BB02 2020 - 2021 Strains:

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Product monograph including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

www.astrazeneca.ca

Product Monograph Master Template Template date: September 2020 FORXIGA (dapagliflozin propanediol monohydrate) Page 1of 75 COPYRIGHT 2014-2021 ASTRAZENECA CANADA INC PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION FORXIGA® Dapagliflozin propanediol monohydrate Tablets, 5 mg and 10 mg, Oral ATC Code: A10BK01

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Product monograph including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

covid-vaccine.canada.ca

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SPIKEVAX™ Elasomeran mRNA vaccine Dispersion for intramuscular injection Multidose Vial, 100 mcg / 0.5mL Active Immunizing Agent Submission Control Number: 259289 ModernaTX, Inc. 200 Technology Square Cambridge, MA, USA, 02139 Imported and Distributed by: Innomar Strategies, Inc.

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Product monograph including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

covid-vaccine.canada.ca

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrCasirivimab and imdevimab for injection Solutions for infusion, each available as 1332 mg/11.1 mL and 300 mg/2.5 mL (120mg/mL) single-use vials Anti-SARS-CoV-2 spike protein monoclonal antibodies HEALTH CANADA HAS AUTHORIZED THE SALE OF THIS COVID-19 DRUG BASED ON …

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Product monograph including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

pdf.hres.ca

Rhesus alloimmunisation The use of Mifegymiso requires measures to prevent rhesus alloimmunisation. Serious Warnings and Precautions It is important that all patients be followed by a physician 7 to 14 days after taking mifepristone to confirm safety and complete pregnancy termination (see WARNINGS AND

  Product, Patients, Monographs, Including, Product monograph including patient, Alloimmunisation

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

ca.gsk.com

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by allknown subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga …

  Information, Product, Patients, Monographs, Medication, Including, Product monograph including patient, Engerix, Product monograph including patient medication information engerix

Labeling &lt;7&gt; Type of Posting Posting Date Official Date ...

Labeling <7> Type of Posting Posting Date Official Date ...

www.uspnf.com

Aug 30, 2019 · , Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations). Labeling The labeling clearly states the specific salt form of the active moiety that is present in the product or preparation because this information may be useful to practitioners and patients. The names and strengths of both the active moiety ...

  Information, Product, Monographs

PRODUCT MONOGRAPH - Pfizer Canada

PRODUCT MONOGRAPH - Pfizer Canada

www.pfizer.ca

Prevnar® 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph Page 7of 61 3. Adults 18Years and Older Safety was assessed in 7 clinical studies including 91,593 adults ranging in ages from 18 to 101 years. Prevnar 13 was administered to 48,806 adults; 2,616 adults were aged 50-64 years and 45,291 adults were 65 years and older.

  Product, Monographs, Including, Product monograph

PART III: CONSUMER INFORMATION INSPIOLTO RESPIMAT …

PART III: CONSUMER INFORMATION INSPIOLTO RESPIMAT …

www.boehringer-ingelheim.ca

Inspiolto® Respimat ® Product Monograph Page 43 of 50 PART III: CONSUMER INFORMATION ... CONSUMER INFORMATION . ... including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines. ...

  Information, Product, Monographs, Consumer, Including, Product monograph, Consumer information

PRODUCT MONOGRAPH SYMBICORT …

PRODUCT MONOGRAPH SYMBICORT …

www.astrazeneca.ca

indicated for the maintenance treatment of moderate to severe COPD including chronic bronchitis and emphysema, in patients with persistent symptoms and a history of exacerbations, where the use of a combination product is considered appropriate. SYMBICORTTURBUHALER is NOT indicated for the relief of acute bronchospasm in COPD patients.

  Product, Monographs, Including, Product monograph

Forxiga Consumer Information - AstraZeneca

Forxiga Consumer Information - AstraZeneca

www.astrazeneca.ca

Product Monograph Master Template Template date: September 2020 FORXIGA (dapagliflozin propanediol monohydrate) Page 3 of 8 COPYRIGHT 2014-2021 ASTRAZENECA CANADA INC FORXIGA and when to start taking it again. have a sudden reduction in your insulin dose have a history of DKA. • are older than 65 years of age

  Information, Product, Monographs, Consumer, Product monograph, Consumer information

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

www.caddra.ca

PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST® methylphenidate hydrochloride . Controlled Release Capsules . 25 mg, 35 mg, 45 mg, 55 mg, 70 mg, 85 mg and 100 mg . Professed Standard . Central Nervous System Stimulant . Purdue Pharma 575 Granite Court

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information

REVISION OF MONOGRAPH ON TABLETS

REVISION OF MONOGRAPH ON TABLETS

www.who.int

Soluble tablets disintegrate within 3 minutes when examined by 5.3 Disintegration test for tablets and capsules, but using water R at 15–25° C. Dispersible tablets Definition Dispersible tablets are uncoated tablets or film-coated tablets intended to be dispersed in water before administration giving a homogeneous dispersion.

  Monographs, Tablets, Revisions, Revision of monograph on tablets

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH INCLUDING PATIENT

www.novonordisk.ca

Product Monograph OZEMPIC® semaglutide injection Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PROZEMPIC® semaglutide injection . 2 mg/pen (1.34 mg/mL) 4 mg/pen (1.34 mg/mL) Pre-filled pen delivering doses of 0.25 mg or 0.5 mg . and . Pre-filled pen delivering doses of 1 mg . ATC code: A10BJ06 ...

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information

Monograph ID / INCI Names (12/18/2020)

Monograph ID / INCI Names (12/18/2020)

eservices.personalcarecouncil.org

193 Amyl Acetate 194 Amylase 195 Amylopectin 196 Amyl Salicylate 197 Anethole 201 Annatto ... 342 Butyl Benzyl Phthalate 343 Butylene Glycol 344 Butyl Ester of Ethylene/MA Copolymer 345 Butyl Ester of PVM/MA Copolymer ... 457 Cellulose Gum 458 Ceresin 459 Cetalkonium Chloride 460 Cetearalkonium Bromide 461 Ceteareth-2

  Name, Monographs, Cellulose, Inci, Acetate, Phthalates, Monograph id inci names

Guideline on specifications: test procedures and ...

Guideline on specifications: test procedures and ...

www.ema.europa.eu

69 specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and 70 herbal medicinal products/traditional herbal medicinal products’ were introduced, which take into 71 account new and revised guidelines, the European Pharmacopoeia revised general monograph ‘Herbals

  Monographs, Herbal

products1/traditional herbal medicinal products

products1/traditional herbal medicinal products

www.ema.europa.eu

the European Pharmacopoeia revised general monograph ‘Herbals Drugs’, as well as new requirements for impurities. Given the nature of this update, a concept paper or public consultation ... for human herbal medicinal products and Part 2 of Annex I to Directive 2001/82/EC as amended for

  Monographs, Herbal

Medicinal Uses for Herbal Teas: Evidence, Dosing, and ...

Medicinal Uses for Herbal Teas: Evidence, Dosing, and ...

www.fammed.wisc.edu

Sep 28, 2007 · This monograph evaluates the scientific evidence for 10 common herbal tea preparations and their effectiveness. There are many other common herbal teas used medicinally; these 10 were chosen as the focus of this Supplement Sampler edition for their good safety profiles, lower drug-herb interaction

  Monographs, Uses, Medicinal, Herbal, Ates, Medicinal uses for herbal teas

The Globalisation of the Pharmaceutical Industry Monograph

The Globalisation of the Pharmaceutical Industry Monograph

www.ifpma.org

Pharmaceuticals Policy and Law 18 (2016) 1–4 1 DOI 10.3233/PPL-160427 IOS Press Editorial – The innovation and access to landscape Jose Luis Valverdea,∗ and Eduardo Pisanib aChair Jean Monnet of EU Law, Granada, Spain bInternational Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

  Monographs

How to use the BP - British Pharmacopoeia

How to use the BP - British Pharmacopoeia

www.pharmacopoeia.com

preparation BP monograph can be found in the next section of this guide. Herbal Drugs, Herbal Drug Preparations and Herbal Medicinal Products / Materials for use in the Manufacture of Homoeopathic Preparations / Blood-related Products / Immunological Products / Radiopharmaceutical Preparations / Surgical Materials

  Monographs, Herbal, How to use the bp

Overview of USP General Chapters &lt;476&gt; and &lt;1086&gt;

Overview of USP General Chapters <476> and <1086>

www.usp.org

Oct 19, 2017 · radiopharmaceuticals, herbal and crude products of animal or plant origin Introduces the following limits: ... and that monograph procedure does not detect an impurity present in the substance, the amount and identity of the impurity, where both are known, shall be stated in the labeling (certificate of analysis) of the official substance ...

  Monographs, Herbal

This document is referenced in USP General Chapter &lt;1121 ...

This document is referenced in USP General Chapter <1121 ...

www.usp.org

the monograph title (e.g. Acetaminophen and Codeine Phosphate Tablets). o Where the vehicle is therapeutically active or equivalent to another component, the word “and” is used in the monograph title (e.g., Dextrose and Sodium Chloride Injection). • Use of the term “in”:

  General, Chapter, Monographs, Referenced, Referenced in usp general chapter

PRODUCT MONOGRAPH

PRODUCT MONOGRAPH

pdf.hres.ca

Response to all diabetic therapies should be monitored by periodic measurements of blood glucose and HbA1c levels, with a goal of decreasing these levels towards the normal range. HbA1c is especially useful for evaluating long-term glycemic control.1 Sitagliptin is substantially excreted by the kidney.

  Product, Monographs, Diabetic, Product monograph

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …

covid-vaccine.canada.ca

Anaphylaxis has been reported. As with all vaccines, training for immunizers, and appropriate medical treatment and supervision after immunization should always be readily available in case of rare anaphylactic reactions following administration of this vaccine. Vaccine recipients

  Product, Monographs, Product monograph, Immunizer

ENGERIX-B

ENGERIX-B

pdf.hres.ca

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by all known subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga Road

  Information, Product, Patients, Monographs, Medication, Including, Engerix, Product monograph including patient medication information engerix

REVISION OF MONOGRAPH ON CAPSULES

REVISION OF MONOGRAPH ON CAPSULES

www.who.int

International Pharmacopoeia. Capsules The requirements of this monograph do not necessarily apply to preparations that are intended for use other than by oral administration, such as vaginal or rectal capsules etc. Such preparations may require a special formulation, method of manufacture, or form of

  International, Monographs, Preparation, Capsule, Revisions, Pharmacopoeia, Revision of monograph on capsules, International pharmacopoeia

Fluzone High Dose - Sanofi

Fluzone High Dose - Sanofi

products.sanofi.ca

Sanofi Pasteur Product Monograph 372 - FLUZONE® High-Dose Page 3 of 23 FLUZONE® High-Dose Influenza Virus Vaccine Trivalent Types A and B (Split Virion) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration: Intramuscular injection. Dosage Form/Strength: Suspension for injection. Active …

  Information, Product, Monographs, Product information, Product monograph, Fluzone

Similar queries